Skip to main content
. 2014 Apr 22;77(5):808–820. doi: 10.1111/bcp.12263

Table 4.

Summary of fluticasone furoate pharmacokinetic parameters following inhaled FF 200 μg repeat dose and statistical analysis results

Parameter (units) Caucasian subjects n = 19 Chinese subjects n = 20 Japanese subjects n = 20 Korean subjects n = 20 Statistical comparison
n Geometric mean (95% CI) n Geometric mean (95% CI) n Geometric mean (95% CI) n Geometric mean (95% CI) Ethnic group comparison Ratio of adjusted geometric mean 90% CI of ratio
Cmax (pg ml−1) 18 41.1(32.8, 51.5)
20 66.9(57.5, 77.9)
20 55.7(46.6, 66.5)
20 72.3(65.9, 79.3)
Chinese : Caucasian 1.637 (1.361, 1.969)
Japanese : Caucasian 1.373 (1.141, 1.653)
Korean : Caucasian 1.776 (1.477, 2.137)
tmax(h)* 18 0.50(0.25–3.00)
20 0.50(0.25–4.00)
20 0.50(0.25–4.00)
20 0.50(0.25–2.00)
Chinese : Caucasian NC NC
Japanese : Caucasian
Korean : Caucasian
AUC(0,tlast) (pg ml−1 h) 18 222(135, 366)
20 588(454, 761)
20 430(317, 584)
20 607(536, 686)
Chinese : Caucasian NC NC
Japanese : Caucasian
Korean : Caucasian
AUC(0,24 h) (pg ml−1 h) 9 541(440, 666)
18 680(603, 767)
16 561(454, 694)
19 629(566, 698)
Chinese : Caucasian 1.487 (1.190, 1.858)
Japanese : Caucasian 1.274 (1.015, 1.598)
Korean : Caucasian 1.439 (1.153, 1.797)
*

Median (range). AUC(0,24 h), area under the concentration time curve from time zero to 24 h; AUC(0,tlast), area under the concentration–time curve from time zero to time of last quantifiable concentration; CI, confidence interval; Cmax, maximum concentration; n, number of subjects for whom pharmacokinetic parameter was derived; NC, statistical comparison not conducted; tmax, time to maximum concentration.